e-therapeutics Announces Business Updates and Interim Results

Contributed by: GlobeNewswire

Tags

Biotech

More Like This

iTeos Reports Third Quarter 2024 Financial Results and Provides Business Updates

iTeos Reports Third Quarter 2023 Financial Results and Provides Business Updates

iTeos Reports First Quarter 2024 Financial Results and Provides Business Updates

iTeos Reports Second Quarter 2024 Financial Results and Provides Business Updates

iTeos Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates

Business Wire logo

Silence Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Business Wire logo

BenevolentAI Interim Results for the Six Months Ended 30 June 2024

iTeos Therapeutics Announces Late-Breaking Oral Presentation of Phase 2 GALAXIES Lung-201 Interim Data at the European Society for Medical Oncology Congress 2024